EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 229 filers reported holding EDITAS MEDICINE INC in Q4 2019. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $697,892 | -10.2% | 96,261 | +9.9% | 0.02% | -13.6% |
| Q4 2022 | $777,154 | -13.6% | 87,616 | +15.1% | 0.02% | -15.4% |
| Q2 2022 | $900,000 | -31.7% | 76,098 | +9.8% | 0.03% | 0.0% |
| Q1 2022 | $1,318,000 | -3.8% | 69,276 | +34.3% | 0.03% | -3.7% |
| Q4 2021 | $1,370,000 | +26.9% | 51,600 | +96.2% | 0.03% | -3.6% |
| Q3 2021 | $1,080,000 | -80.1% | 26,302 | -72.6% | 0.03% | -83.7% |
| Q2 2021 | $5,432,000 | +82.3% | 95,901 | +35.2% | 0.17% | +55.0% |
| Q1 2021 | $2,979,000 | -15.7% | 70,935 | +40.7% | 0.11% | -32.3% |
| Q4 2020 | $3,535,000 | +1036.7% | 50,414 | +355.5% | 0.16% | +811.1% |
| Q3 2020 | $311,000 | +48.8% | 11,068 | +56.8% | 0.02% | -48.6% |
| Q2 2020 | $209,000 | +216.7% | 7,060 | +110.6% | 0.04% | -2.8% |
| Q1 2020 | $66,000 | +43.5% | 3,352 | +117.7% | 0.04% | +260.0% |
| Q4 2019 | $46,000 | – | 1,540 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |